50
Participants
Start Date
January 31, 2017
Primary Completion Date
June 30, 2023
Study Completion Date
August 31, 2023
Vernakalant
Initial infusion: 3 mg/kg intravenously over a 10 minute period. For patients weighing ≥ 113 kg, the maximum initial dose will be 339 mg. If conversion to sinus rhythm does not occur within 15 minutes after the end of the initial infusion, a second 10 minute infusion of 2 mg/kg will be administered. For patients weighing ≥ 113 kg, the maximum second infusion will be 226 mg.
Flecainide
2 mg /kg (max 150 mg) intravenously over 10 minutes.
Hospital Clínico Universitario San Carlos, Madrid
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
OTHER
David Filgueiras-Rama
OTHER